Alex Garner will work to further expand and strengthen Avomeen’s formulation and clinical trial manufacturing capabilities to support biopharmaceutical clients.
Anshul Gupte will be responsible for technical and scientific oversight of client projects, reporting to John Ross, President of Metrics Contract Services.
CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.
JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.
Hiring is up, recruiters say, and soft skills are in short supply. Survey respondents say they’re happy now, but will likely change employers within five years.
As use of outsourcing increases, more companies see it as strategic, and relationships with service providers as partnerships. However, basic communications, vendor oversight and information transfer remain challenges.
Imperial Innovations, the commercialization arm of Imperial College, has launched IR Pharma Ltd., a new company targeting contract services for the respiratory disease sector of the pharmaceutical industry.
The Kansas City District Office of the FDA submitted a recommendation of approval to the Center for Drug Evaluation and Research for The University of Iowa Pharmaceuticals (UIP) to manufacture an aseptically filled sterile, prescription drug product for a
Avid Bioservices, Inc. and Boehringer Ingelheim have entered into a global strategic production alliance agreement, under which Avid will become an approved member of BI's global Production Alliance Network (PAN) Biologics.
Editor Gil Roth profiles the top companies in the various pharma and biopharma outsourcing arenas, with analyst perspective from investment analyst Michael Martorelli.